Sponsored by the University of Maryland School of Medicine
Department of Emergency Medicine
EMERGENCY MEDICINE GRAND ROUNDS AND CONFERENCE SERIES
THE CRITICALLY ILL OBESE PATIENT
University of Maryland
Upon completion of this activity, participants should be able to: • List the physiologic effects of obesity on the pulmonary and circulatory systems.
• Discuss the importance of patient positioning in airway and ventilator management of the critically ill obese patient
• Identify high-risk medications and discuss weight-based dosing for the critically ill obese patient
It is the policy of the University of Maryland School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, all persons in a position to control the educational content of this regularly scheduled series must disclose any relevant financial relationships they have with commercial interests. Any identified conflicts of interest must be resolved prior to speaker's presentation.
The organizers listed below have disclosed no relevant financial relationships with commercial interests: Gentry Wilkerson MD, Sarah Dubbs MD, Michael Bond MD, Semhar Tewelde MD, Janae Yates
The individuals listed below have disclosed relevant financial relationships with commercial interests: NONE
Mike Winters,MD, has no relevant financial relationships to disclose.
University of Maryland School of Medicine Office of CME staff members have disclosed no relevant financial relationships.
of Maryland School of Medicine is accredited by the Accreditation
Council for Continuing Medical Education to provide
continuing medical education for physicians.
of Maryland School of Medicine designates this live
activity for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent
of their participation in the activity.
of Off-Label or Investigational Uses or Products:
Presentations in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. The audience is advised to consult the full prescribing information of all drugs or devices prior to use.